A randomised phase II trial of dexamethasone and aspirin (DA) versus dexamethasone, diethylstilboestrol and aspirin (DAS) in locally advanced or metastatic cancer of the prostate

Phase 2

Completed

• Conditions: Prostate cancer; Cancer; Malignant neoplasm of the prostate

• Registration Number: ISRCTN13255144
• Lead Sponsor: Department of Health (UK)

Brief Summary

2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21285990

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-09-12
• Study Completion: 2005-01-01
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 260

Inclusion Criteria

North East Thames region (Whipps Cross, Oldchurch, King George, St. Bartholomew's).
Patients over the age of 18 years who have locally advanced metastatic prostate specific antigen (PSA)-positive adenocarcinoma after failure of gonadotropin releasing hormone (GnRH) analogue therapy, radiation therapy, surgery or any combination of these.

Exclusion Criteria

Not provided at time of registration

Study & Design

• Study Type: Interventional
• Study Design: Not specified